首页> 外文期刊>Revista de salud animal >THERAPEUTIC EFFICACYOF IVERMECTIN SUBCUTANEOUSLY IN THE COREOLOF CANINE GENERALIZED WET DEMODICOSIS
【24h】

THERAPEUTIC EFFICACYOF IVERMECTIN SUBCUTANEOUSLY IN THE COREOLOF CANINE GENERALIZED WET DEMODICOSIS

机译:依维替林在皮脂增生性毛细血管的皮脂中的治疗功效

获取原文
           

摘要

With the objective of evaluate the efficacy of the Ivermectin for subcutaneous route opposite to the canine humid generalized demodicosis, there were investigated 120 dogs that were presenting this clinical form of the demodecia. It were formed three groups of 40 dogs each one, of different races and between 4 and 12 months of age. Previously, it was proven that they didn’t go positive to dirofilariasis. The control group was treated with amitraz. A second group talked once to subcutaneous Ivermectina for week and the third, it was treated with Ivermectina more support therapy. The therapeutic protocol applied to the group three had an efficacy similar to the agreement with amitraz (control), by what this protocol could be used for the treatment of this entity and the biggest number of convalescent animals it was obtained in the week 12. We recommend expanding the time of evaluation of the therapeutic protocols; so that the possible relapses they can be evaluated.
机译:为了评估伊维菌素在与犬湿润普遍性蠕形螨病相反的皮下途径中的功效,研究了120只表现出这种脱失型临床表现的狗。它由三组组成,每组40只狗,不同种族,年龄在4到12个月之间。以前,已经证明他们对铁丝虫病没有积极作用。对照组用阿米特拉治疗。第二组与皮下Ivermectina交谈了一周,第三组接受了Ivermectina更多支持疗法的治疗。应用于第3组的治疗方案的功效类似于与阿米特拉斯(对照)达成的协议,该方案可用于治疗该实体以及在第12周获得的最大数量的康复动物。建议延长治疗方案的评估时间;这样就可以评估可能的复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号